Get the Stockscreener App
4.33
5.66%
-0.26
After Hours:
4.37
0.04
+0.92%
Calcimedica Inc stock is traded at $4.33, with a volume of 61,151.
It is down -5.66% in the last 24 hours and up +29.64% over the past month.
CalciMedica Inc is a clinical-stage biopharmaceutical company focused on developing therapeutics that treat serious illnesses driven by inflammatory and immunologic processes and direct cellular damage. Its product candidates act upon calcium release-activated calcium (CRAC) channels and would constitute a new class of drugs. Its product candidate is Auxora, a potent and selective intravenous formulated small molecule CRAC channel inhibitor containing the active compound zegocractin (formerly referred to as CM4620) that, in animal models, reduced acute epithelial and/or endothelial cell injury and inflammation in organs, such as the pancreas, lungs and kidneys.
See More
Previous Close:
$4.59
Open:
$4.52
24h Volume:
61,151
Relative Volume:
0.88
Market Cap:
$62.39M
Revenue:
-
Net Income/Loss:
$-20.87M
P/E Ratio:
-2.7192
EPS:
-1.5924
Net Cash Flow:
$-21.21M
1W Performance:
-0.92%
1M Performance:
+29.64%
6M Performance:
+147.43%
1Y Performance:
+55.20%
1-Day Range:
$4.26
$4.59
1-Week Range:
$4.09
$4.75
52-Week Range:
$1.42
$4.815
Calcimedica Inc Stock (CALC) Company Profile
Name
Calcimedica Inc
Sector
Industry
Phone
858-952-5500
Address
505 COAST BOULEVARD SOUTH, LA JOLLA
Compare CALC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CALC
Calcimedica Inc
|
4.33 | 66.14M | 0 | -20.87M | -21.21M | -1.5924 |
|
VRTX
Vertex Pharmaceuticals Inc
|
452.04 | 113.14B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
741.29 | 78.49B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
877.94 | 54.76B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
397.55 | 54.51B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
197.01 | 41.64B | 447.02M | -1.18B | -906.14M | -6.1812 |
Calcimedica Inc Stock (CALC) Latest News
Financial Contrast: CalciMedica (NASDAQ:CALC) and GRI Bio (NASDAQ:GRI) - Defense World
Stonepine Capital Management LLC Has $136,000 Stock Position in CalciMedica Inc. $CALC - MarketBeat
Why retail investors favor CalciMedica Inc. stockJuly 2025 Closing Moves & Weekly Top Gainers Alerts - Newser
CalciMedica (CALC) Stock Analysis Report | Financials & Insights - Benzinga
Oppenheimer reiterates Outperform rating on CalciMedica stock ahead of key trial - Investing.com Australia
Oppenheimer reiterates Outperform rating on CalciMedica stock ahead of key trial By Investing.com - Investing.com South Africa
CalciMedica announces presentation of data from Preclinical Study of Auxora - MSN
Is CalciMedica Inc. stock a smart buy before Fed meetingQuarterly Trade Summary & Capital Efficiency Focused Ideas - newser.com
From Calcium Channels To Cash Runway: Why CalciMedica Is A Stock To Watch - RTTNews
Will CalciMedica Inc. stock pay special dividendsJuly 2025 Action & Target Return Focused Picks - newser.com
What MACD and RSI say about CalciMedica Inc.July 2025 Outlook & Consistent Profit Alerts - newser.com
Technical signs of recovery in CalciMedica Inc.2025 Macro Impact & Step-by-Step Trade Execution Guides - newser.com
Is CalciMedica Inc. still worth holding after the dipTrade Entry Report & AI Forecasted Entry/Exit Points - newser.com
Is CalciMedica Inc. stock near bottom after declinePortfolio Profit Report & Daily Oversold Bounce Ideas - newser.com
What recovery options are there for CalciMedica Inc.2025 Year in Review & Fast Moving Stock Trade Plans - newser.com
Is CalciMedica Inc. stock reversal real or fakeGap Down & Weekly Return Optimization Plans - newser.com
Tools to monitor CalciMedica Inc. recovery probability2025 Market Trends & Expert Curated Trade Ideas - newser.com
Best data tools to analyze CalciMedica Inc. stockTrade Performance Summary & AI Powered Buy/Sell Recommendations - newser.com
How to build a custom watchlist for CalciMedica Inc.July 2025 Catalysts & Smart Swing Trading Alerts - newser.com
Analyzing CalciMedica Inc. with risk reward ratio chartsJuly 2025 Retail & Free Reliable Trade Execution Plans - newser.com
Why CalciMedica Inc. stock remains on buy listsJuly 2025 Pullbacks & Weekly Market Pulse Updates - newser.com
Should I hold or sell CalciMedica Inc. stock in 2025Market Rally & Scalable Portfolio Growth Methods - newser.com
Can CalciMedica Inc. recover in the next quarterWeekly Profit Recap & Reliable Volume Spike Alerts - newser.com
Will CalciMedica Inc. stock return to pre crisis levelsJuly 2025 Update & Growth Focused Entry Reports - Fundação Cultural do Pará
CalciMedica Pushes Forward Despite Widening Losses And Rising R&D Costs - Finimize
Analyzing drawdowns of CalciMedica Inc. with statistical tools2025 Technical Overview & Stock Portfolio Risk Management - newser.com
Calcimedica Inc Stock (CALC) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.08%
0.91%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):